Related references
Note: Only part of the references are listed.EGFR and anti-EGFR nanobodies: review and update
Jafar Sharifi et al.
JOURNAL OF DRUG TARGETING (2021)
Paper Title Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody
Jafar Sharifi et al.
MOLECULAR BIOTECHNOLOGY (2021)
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Emily Y. Jen et al.
CLINICAL CANCER RESEARCH (2020)
HER2-specific immunotoxins constructed based on single-domain antibodies and the improved toxin PE24X7
Li Cao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
Xiaojing Chi et al.
NATURE COMMUNICATIONS (2020)
Preparation and characterization of humanized nanobodies targeting the dimer interface of epidermal growth factor receptor (EGFR)
He Zhu et al.
PROTEIN EXPRESSION AND PURIFICATION (2019)
From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
Volker Schirrmacher
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Innovative approaches for cancer treatment: current perspectives and new challenges
Carlotta Pucci et al.
ECANCERMEDICALSCIENCE (2019)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Potential impact of invasive surgical procedures on primary tumor growth and metastasis
Maria Alieva et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo
Ronit Mazor et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
Yuan Yu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro
Cuimin Deng et al.
ONCOTARGET (2017)
Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A
Bahman Akbari et al.
ANTI-CANCER DRUGS (2017)
New Life for Immunotoxin Cancer Therapy
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2016)
Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology
Leila Rahbarnia et al.
BIOLOGICALS (2016)
Immunogenicity of therapeutic recombinant immunotoxins
Ronit Mazor et al.
IMMUNOLOGICAL REVIEWS (2016)
Pseudomonas aeruginosa and Its Bacterial Components Influence the Cytokine Response in Thymocytes and Splenocytes
Andreas Weber et al.
INFECTION AND IMMUNITY (2016)
Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR)
Shiva Ahdi Khosroshahi et al.
PROTEIN EXPRESSION AND PURIFICATION (2016)
Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)
Bahman Akbari et al.
PROTEIN EXPRESSION AND PURIFICATION (2016)
Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus
Marta Borowiec et al.
TOXINS (2016)
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
Ronit Mazor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
High-yield production of functional soluble single-domain antibodies in the cytoplasm of Escherichia coli
Kristof Zarschler et al.
MICROBIAL CELL FACTORIES (2013)
Immunotoxins: The Role of the Toxin
Antonella Antignani et al.
TOXINS (2013)
Mechanisms and insights into drug resistance in cancer
Hiba Zahreddine et al.
FRONTIERS IN PHARMACOLOGY (2013)
Therapeutic targets and recent advances in protein immunotoxins
J. Madhumathi et al.
CURRENT OPINION IN MICROBIOLOGY (2012)
A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
John E. Weldon et al.
FEBS JOURNAL (2011)
A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
Rob C. Roovers et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Differential tumor-targeting abilities of three single-domain antibody formats
Andrea Bell et al.
CANCER LETTERS (2010)
A Recombinant Immunotoxin Targeting CD22 With Low Immunogenicity, Low Nonspecific Toxicity, and High Antitumor Activity in Mice
Johanna K. Hansen et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Aprotease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity
John E. Weldon et al.
BLOOD (2009)
Processing of Pseudomonas aeruginosa Exotoxin A Is Dispensable for Cell Intoxication
Juliette Morlon-Guyot et al.
INFECTION AND IMMUNITY (2009)
General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
Cecile Vincke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT
Lea Olive Tchouate Gainkam et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Immunotoxin treatment of cancer
Ira Pastan et al.
ANNUAL REVIEW OF MEDICINE (2007)
Immunotoxins for targeted cancer therapy
Robert J. Kreitman
AAPS JOURNAL (2006)
Epidermal growth factor receptor: a promising target in solid tumours
JJ Laskin et al.
CANCER TREATMENT REVIEWS (2004)
Monoclonal antibodies for brain tumour treatment
A Boskovitz et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in Escherichia coli
JQ Guo et al.
JOURNAL OF BIOTECHNOLOGY (2003)
The ErbB receptors and their role in cancer progression
T Holbro et al.
EXPERIMENTAL CELL RESEARCH (2003)
Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity
JE Wedekind et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Chemical construction of immunotoxins
V Ghetie et al.
MOLECULAR BIOTECHNOLOGY (2001)
Production of a single-chain variable fragment antibody recognizing type III mutant epidermal growth factor receptor
N Nakayashiki et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2000)
Share Paper
